MedPath

Evaluation of Cognitive Function in a Suicidal Crisis

Conditions
Suicide
Registration Number
NCT03519802
Lead Sponsor
University Hospital, Lille
Brief Summary

The aftermath of suicide is devastating, being the cause of 800 000 deaths every year worldwide. In France, suicide still causes about 10 000 deaths per year and the number of suicide attempts (SA) is estimated between 170 000 and 200 000 per year (InVS).

It is often thought that a suicidal crisis is only related to depression, as it actually is a far more complex phenomenon. A suicidal crisis can occur on various grounds like psychiatric disorders but also contextual events or somatic diseases and it has been hypothesized that suicidal ideas or inclinations could have a common and independent cognitive origin

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
165
Inclusion Criteria
  • Normal or corrected vision
  • Having understood the information not and having signed the form of consent
  • Being hospitalized for suicidal ideas (Score with inclusion at the level of Beck > 3) or after a suicide attempt of less than one week.

Exclusion criteria:

  • Pregnant woman and/or nursing
  • Diagnosed irrational pathology
  • Known proven intellectual deficiency
  • Patient whose physical or mental status does not allow to pass the tests of the study
  • Being under supervision or trusteeship or private of freedom or in emergency
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of patients having a score in MoCA test strictly under 26at inclusion
Secondary Outcome Measures
NameTimeMethod
Variation in MoCA test scores between before (V1) and after hospitalization (V2)an average at 3 months after inclusion
Variation in scores to the subtests between between before (V1) and after hospitalization (V2)an average at 3 months after inclusion
Rate of patients having lower subtests scores than the standardsan average at 3 months after inclusion

Trial Locations

Locations (1)

CHRU,Hôpital Fontan

🇫🇷

Lille, France

© Copyright 2025. All Rights Reserved by MedPath